Home » Posts tagged 'SEBs'

SEBs

Bringing Biologics in from the Cold: Does Canada’s IP Regime Need a Booster?

Bringing Biologics in from the Cold: Does Canada’s IP Regime Need a Booster?

As ratification stutters for the Comprehensive Economic and Trade Agreement (CETA), the much-maligned free-trade deal between Canada and the European Union, debate continues as to whether the Canadian intellectual property (IP) regime will provide adequate protection for innovative biologic medicines in relation to subsequent-entry biologics (SEBs). Biologic medicines are complex molecules derived from living organisms […]